DCS Pharma
DCS Pharma, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2005, the company has established a strong presence across Europe and beyond, focusing on critical areas such as drug formulation, manufacturing, and supply chain management. DCS Pharma is renowned for its commitment to quality and compliance, offering a range of core products and services that cater to the unique needs of healthcare providers and patients alike. With a reputation for excellence, the company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. As a trusted name in the pharmaceutical sector, DCS Pharma continues to drive advancements in healthcare, ensuring the delivery of effective and safe therapeutic options.
DitchCarbon Score
How does DCS Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
DCS Pharma's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
DCS Pharma's reported carbon emissions
DCS Pharma, headquartered in Great Britain, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. In the absence of detailed emissions data, it is important to note that DCS Pharma has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly focuses on sustainability and reducing carbon footprints, DCS Pharma's future commitments and initiatives will be crucial in aligning with industry standards and addressing climate change effectively.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
DCS Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
